Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy

As the USA faces a worsening overdose crisis, improving access to evidence-based treatment for opioid use disorder (OUD) remains a policy priority. Federal regulatory changes in response to the COVID-19 pandemic substantially expanded flexibilities on take-home doses for methadone treatment for OUD....

Descripción completa

Detalles Bibliográficos
Autores principales: Krawczyk, Noa, Rivera, Bianca D, Levin, Emily, Dooling, Bridget C E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949855/
https://www.ncbi.nlm.nih.gov/pubmed/36841564
http://dx.doi.org/10.1016/S2468-2667(23)00023-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949855/
https://www.ncbi.nlm.nih.gov/pubmed/36841564
http://dx.doi.org/10.1016/S2468-2667(23)00023-3

Ejemplares similares